265 related articles for article (PubMed ID: 12700504)
1. [First line therapy for Helicobacter pylori eradication in France].
Dupas JL
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):467-72. PubMed ID: 12700504
[TBL] [Abstract][Full Text] [Related]
2. [How to treat after Helicobacter pylori eradication failure?].
Bruley des Varannes S
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):478-83. PubMed ID: 12700506
[TBL] [Abstract][Full Text] [Related]
3. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome.
Adamek RJ; Suerbaum S; Pfaffenbach B; Opferkuch W
Am J Gastroenterol; 1998 Mar; 93(3):386-9. PubMed ID: 9517645
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
6. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
[TBL] [Abstract][Full Text] [Related]
8. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years.
Kadayifci A; Buyukhatipoglu H; Cemil Savas M; Simsek I
Clin Ther; 2006 Nov; 28(11):1960-6. PubMed ID: 17213016
[TBL] [Abstract][Full Text] [Related]
9. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
10. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
11. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
12. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB
Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829
[TBL] [Abstract][Full Text] [Related]
14. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of Helicobacter pylori infection].
Lamouliatte H; Cayla R; Mégraud F
Rev Prat; 2000 Sep; 50(13):1442-5. PubMed ID: 11019637
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of two triple-therapy regimens with metronidazole or clarithromycin for the eradication of H. pylori infection in Vietnamese children: a randomized, double-blind clinical trial.
Nguyen TV; Bengtsson C; Nguyen GK; Hoang TT; Phung DC; Sörberg M; Granström M
Helicobacter; 2008 Dec; 13(6):550-6. PubMed ID: 19166421
[TBL] [Abstract][Full Text] [Related]
17. My approach to Helicobacter pylori eradication.
Bazzoli F
Eur J Gastroenterol Hepatol; 1999 Jun; 11 Suppl 1():S37-41. PubMed ID: 10443911
[TBL] [Abstract][Full Text] [Related]
18. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
Bazzoli F; Zagari RM; Pozzato P; Fossi S; Ricciardiello L; Nicolini G; De Luca L; Berretti D; Alampi G; Di Pietro C; Morelli P; Roda E
Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country.
Fischbach LA; Bravo LE; Zarama GR; Bravo JC; Ojha RP; Priest EL; Collazos T; Casabon AL; Guerrero LZ; Singh KP; Correa P
Helicobacter; 2009 Apr; 14(2):100-8. PubMed ID: 19298337
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]